contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


intellego-announces-cancellation-of-moveomed-transaction

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Intellego Technologies is a company active in photochromic indicator technology. The company supplies photochromic inks that design visual indicators that enable the effects of invisible ultraviolet light to be seen. The ink changes color based on exposure to ultraviolet radiation or specific substances. The products are primarily used by OEM manufacturers and are used in industry applications globally. Intellego Technologies was founded in 2011 and is headquartered in Stockholm.

Intellego Technologies

Intellego Technologies [Intellego] announced in October 2025 that its subsidiary Yuvio Technologies [Yuvio] had received an order from MoveoMed GmbH [MoveoMed] valued at EUR 22 million for UV...

<div class="mfn-preamble"><p><strong>Intellego Technologies [Intellego] announced in October 2025 that its subsidiary Yuvio Technologies [Yuvio] had received an order from MoveoMed GmbH [MoveoMed] valued at EUR 22 million for UV-C disinfection devices to be delivered during 2025. Today MoveoMed informed Intellego, that the order is cancelled.</strong></p></div><div class="mfn-body"><p>As a result of the independent forensic investigation that KPMG is conducting in connection with the criminal suspicions directed against the company's former CEO, Intellego has received information that the terms of the order to Yuvio, including payment and delivery terms, were falsified.</p><p>“Since the previous CEO was arrested on November 18th, we are turning every stone and all transactions are being reviewed”, says Jacob Laurin, Acting CEO Intellego Technologies AB.<br><br>Further information on Intellego’s transactions will follow the independent report from KPMG that will be presented during January, 2026.</p></div><div class="mfn-footer mfn-contacts mfn-79847ae48c06"><p><strong class="mfn-heading-1">Contact</strong></p><hr><p><br></p><p>Jacob Laurin,&nbsp;acting CEO and Board Member, Intellego Technologies AB<br>E-post: <a rel="noopener" href="mailto:jacob.laurin@intellego-technologies.com">jacob.laurin@intellego-technologies.com</a></p></div><div class="mfn-footer mfn-about mfn-d6eb73c4bfb8"><p><strong class="mfn-heading-1">About Us</strong></p><hr><p>Intellego Technologies develops and manufactures color indicators that show the effect of irradiation with, among other things, invisible ultraviolet light, UV light. Color indicators are used globally in, for example, the disinfection industry, the sunscreen industry, and the manufacturing industry. Intellego's indicators have been developed from the company's patented photochromic ink, which can be adapted to different wavelengths of light and various application areas across a range of different industries. Intellego Technologies was founded in 2011, is headquartered in Stockholm, and is listed on the Nasdaq First North Growth Market.</p><p>The company's Certified Adviser on the Nasdaq First North Growth Market Stockholm is Mangold Fondkommission AB.</p><p>Intellego's website: <a rel="noopener" href="https://intellego-technologies.com/en/">https://intellego-technologies.com/en/</a></p><p>Subscribe to Intellego's press releases: <a rel="noopener" href="https://intellego-technologies.com/sv/pressmeddelanden/">https://intellego-technologies.com/sv/pressmeddelanden/</a></p><p>Contact the communications team: <a rel="noopener" href="mailto:communications@intellego-technologies.com">communications@intellego-technologies.com</a></p></div><div class="mfn-footer mfn-regulatory mfn-regulatory-mar"><p><em>This information is information that Intellego Technologies is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-01-03 13:15 CET.</em></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong></p><hr><p><a rel="noopener" href="https://storage.mfn.se/552a8a9f-4d11-4f7f-824e-78733beb207b/intellego-announces-cancellation-of-moveomed-transaction.pdf" class="mfn-generated mfn-primary">Intellego announces cancellation of MoveoMed transaction</a></p></div>

Intellego announces cancellation of MoveoMed transaction

Faron Pharmaceuticals

Herantis Pharma

Mendus

Probabilities of success in drug development

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Solar Foods

Solar Foods is planning a listing on the Nasdaq First North Growth Market Finland marketplace

Return on capital (ROE, ROI, ROIC, RONIC)

The DuPont formula helps understand the dynamics of value creation